All lobbying filings
DENDREON PHARMACEUTICALS, LLC
DENDREON PHARMACEUTICALS, LLC filed a Q2 report for DENDREON PHARMACEUTICALS, LLC on August 19, 2025.
Lobbying for DENDREON PHARMACEUTICALS, LLC
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Aug 19, 2025
Expenses
$58,787
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
1
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.